Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Abatacept for Patients with IgG4-Related Disease
ItalyLong-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy
FranceStudy on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis
AustriaStudy on Semaglutide for Weight Loss in Patients with HIV and Obesity
DenmarkStudy on the Use of Mesenchymal Stem Cells and Sodium Chloride for Patients with Progressive Multiple Sclerosis
NorwayLong-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination
BelgiumStudy on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis
FranceStudy Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis
PolandStudy of Azacitidine Treatment in Patients with VEXAS Syndrome
DenmarkStudy of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis
GermanyStudy on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide
DenmarkStudy of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
